These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 4266967

  • 21. DNCB reactivity in patients with skin carcinoma.
    Bleumink E, Nater JP.
    Dermatologica; 1974; 148(1):44-6. PubMed ID: 4364858
    [No Abstract] [Full Text] [Related]

  • 22. Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program.
    Klein E, Holtermann OA, Helm F, Rosner D, Milgrom H, Adler S, Stoll HL, Case RW, Prior RL, Murphy GP.
    Transplant Proc; 1975 Jun; 7(2):297-315. PubMed ID: 1093298
    [No Abstract] [Full Text] [Related]

  • 23. [Immunotherapy].
    Lejeune FJ, Bernheim JL, Vanwijck R.
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract] [Full Text] [Related]

  • 24. Kaposi's sarcoma: a review and recent developments.
    Safai B, Good RA.
    Clin Bull; 1980 Mar; 10(2):62-9. PubMed ID: 6249516
    [No Abstract] [Full Text] [Related]

  • 25. Immunotherapy of malignant melanoma with vaccinia virus.
    Roenigk HH, Deodhar S, St Jacques R, Burdick K.
    Arch Dermatol; 1974 May; 109(5):668-73. PubMed ID: 4828533
    [No Abstract] [Full Text] [Related]

  • 26. Cell-mediated immunity against malignant melanoma in monozygous twins.
    Nagel GA, St Arneault G, Holland JF, Kirkpatrick D, Kirkpatrick R.
    Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
    [No Abstract] [Full Text] [Related]

  • 27. Cellular reaction to concanavalin A studied by the skin window method in healthy subjects and in patients with malignant tumors.
    Kolár Z, Jansa P, Kovarík J, Skovránková H, Krcová I.
    Acta Univ Palacki Olomuc Fac Med; 1987 Jun; 117():73-80. PubMed ID: 2977713
    [No Abstract] [Full Text] [Related]

  • 28. [Studies of tumor exchange transplantations in inoperable melanomas].
    Gartmann H, Tritsch H.
    Hautarzt; 1966 Dec; 17(12):529-33. PubMed ID: 5994834
    [No Abstract] [Full Text] [Related]

  • 29. Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms.
    Donawho CK, Muller HK, Bucana CD, Kripke ML.
    J Immunol; 1996 Jul 15; 157(2):781-6. PubMed ID: 8752929
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
    Fossati G, Canevari S, Pierotti MA, Vezzoni P, Porta GD, Vaglini M.
    J Natl Cancer Inst; 1979 Jun 15; 62(6):1381-5. PubMed ID: 286110
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Standardized recall antigen testing in patients with malignant melanoma, endogenous eczema patients and healthy humans].
    Stenger D, Delbrück H, Krumrey K, Zaun H.
    Z Hautkr; 1983 Mar 01; 58(5):293-304. PubMed ID: 6845797
    [Abstract] [Full Text] [Related]

  • 35. [Dermal reactions to melanoma autohomogenates].
    Tritsch H.
    Hautarzt; 1970 Jun 01; 21(6):258-65. PubMed ID: 5520644
    [No Abstract] [Full Text] [Related]

  • 36. Recall antigen delayed-type hypersensitivity skin testing in melanoma and acute leukemia patients and their associates.
    Morris DL, Hersh EM, Hsi BP, Gutterman JU, Marshall MM, Mavligit GM.
    Cancer Res; 1979 Jan 01; 39(1):219-26. PubMed ID: 761192
    [No Abstract] [Full Text] [Related]

  • 37. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
    Waanders GA, Rimoldi D, Liénard D, Carrel S, Lejeune F, Dietrich PY, Cerottini JC, Romero P.
    Clin Cancer Res; 1997 May 01; 3(5):685-96. PubMed ID: 9815737
    [Abstract] [Full Text] [Related]

  • 38. Regression of malignant melanoma as a manifestation of a cellular immunity response.
    Lloyd OC.
    Proc R Soc Med; 1969 Jun 01; 62(6):543-5. PubMed ID: 5802725
    [No Abstract] [Full Text] [Related]

  • 39. [Determination of T lymphocytes in blood circulation and cutaneous infiltrates of various dermatoses].
    Panella TE, Rodellas AC, Aguadé JP.
    Med Cutan Ibero Lat Am; 1974 Jun 01; 2(3):213-20. PubMed ID: 4549722
    [No Abstract] [Full Text] [Related]

  • 40. [Some not tumorspecific immunological investigations in malignant neoplasms of skin (author's transl)].
    Salamon T, Stojaković M, Lazović-Tepavac O.
    Dermatol Monatsschr; 1978 Oct 01; 164(10):720-6. PubMed ID: 738491
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.